Dr. Ellis on Neoadjuvant Endocrine Therapy for Breast Cancer

2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic TherapyПодробнее

International Virtual Round Table| Debate: Dr. Matthew Ellis & Dr. Alastair ThompsonПодробнее

International Virtual Round Table featuring: Dr. Matthew J. Ellis, MB, BChir, BSc., PhD, FRCPПодробнее

Heterogeneity in treatment response in patients with luminal breast cancer (Matthew Ellis, USAПодробнее

Dr. Ingrid Mayer discusses neoadjuvant endocrine therapyПодробнее

Dr. Ellis on Resistance to Endocrine Therapy in HR+ Metastatic Breast CancerПодробнее

Dr. Khong on the Benefit of Neoadjuvant Endocrine Therapy in ER+ Breast CancersПодробнее

Challenges With Neoadjuvant Endocrine Therapy in Breast CancerПодробнее

Dr. Holmes on Neoadjuvant Endocrine Therapy in Breast CancerПодробнее

Dr. Judy Boughey on Neoadjuvant Endocrine Therapy in Breast CancerПодробнее

Dr. Matthew J. Ellis on Neoadjuvant Palbociclib in Primary Breast CancerПодробнее

Dr. Ellis Describes Breast Cancer HeterogeneityПодробнее

Dr. Ellis Discusses Ki67 as a Treatment Monitoring BiomarkerПодробнее

Dr. Matthew Ellis on hormonal therapy before breast cancer surgeryПодробнее